首页> Clinical infectious diseases : an official publication of the Infectious Diseases Society of America> Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral Action.

Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral Action.

导出 LinkOut

翻译打印收藏纠错

第一作者： Annelie A,Monnier

第一单位： Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.;Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.;Faculty of Medicine, Research Group of Immunology and Biochemistry, Hasselt University, Belgium.

作者： Annelie A,Monnier ^[1] ; Jeroen,Schouten ^[2] ; Gianpiero,Tebano ^[3] ; Veronica,Zanichelli ^[4] ; Benedikt D,Huttner ^[5] ; Céline,Pulcini ^[6] ; Christine,Årdal ^[7] ; Stephan,Harbarth ^[5] ; Marlies E,Hulscher ^[2] ; Inge C,Gyssens ^[8]

作者单位： Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.;Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.;Faculty of Medicine, Research Group of Immunology and Biochemistry, Hasselt University, Belgium. ^[1] Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. ^[2] Université de Lorraine, APEMAC, Nancy, France. ^[3] Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland. ^[4] Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.;Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Switzerland. ^[5] Université de Lorraine, APEMAC, Nancy, France.;Université de Lorraine, CHRU-Nancy (Centre Hospitalier Régional Universitaire de Nancy), Infectious Diseases Department, France. ^[6] Norwegian Institute of Public Health, Oslo, Norway. ^[7] Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.;Faculty of Medicine, Research Group of Immunology and Biochemistry, Hasselt University, Belgium. ^[8]

关键词 antibiotic access antibiotic discovery antimicrobial resistance barriers and facilitators global health multisectoral stakeholders

医学主题词抗菌药(Anti-Bacterial Agents);临床试验(主题)(Clinical Trials as Topic);抗药性, 微生物(Drug Resistance, Microbial);卫生政策(Health Policy);人类(Humans);公共卫生(Public Health)

DOI 10.1093/cid/ciy824

PMID 30256927

发布时间 2020-08-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交